Unresectable thoracic neuroblastic tumors: Changes in image-defined risk factors after chemotherapy and impact on surgical management.
Xavier DelforgePauline De CambourgAnne-Sophie DefachellesAurore HaffreingueJulien RodIbtissam KassiteNassima ChabaniArthur Lauriot-Dit-PrevostAntoine GourmelAlexis ArnaudCamille DuchesneEstelle ThebaudMarc-David LeclairPublished in: Pediatric blood & cancer (2021)
Tumor volume reduction with neoadjuvant chemotherapy eliminates most IDRF in thoracic neurogenic tumors. Vascular IDRF are rapidly resolved at this site, making surgical resection and minimally invasive surgery possible.